40 related articles for article (PubMed ID: 25104144)
1. Evaluating Prognostic Value of Dynamics of Circulating Lactate Dehydrogenase in Colorectal Cancer Using Modeling and Machine Learning.
Ding H; Yuan M; Yang Y; Gupta M; Xu XS
Clin Pharmacol Ther; 2024 Apr; 115(4):805-814. PubMed ID: 37724436
[TBL] [Abstract][Full Text] [Related]
2. Serum lactate dehydrogenase and survival following cancer diagnosis.
Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Ng T; Van Hemelrijck M
Br J Cancer; 2015 Nov; 113(9):1389-96. PubMed ID: 26469834
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Correlation of Serum IL-17, VEGF, and Lactate Dehydrogenase (LDH) Levels with Prognosis of Gastric Cancer.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9851908. PubMed ID: 38125109
[TBL] [Abstract][Full Text] [Related]
4. Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.
Passardi A; Scarpi E; Tamberi S; Cavanna L; Tassinari D; Fontana A; Pini S; Bernardini I; Accettura C; Ulivi P; Frassineti GL; Amadori D
PLoS One; 2015; 10(8):e0134732. PubMed ID: 26244985
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum lactate and lactate dehydrogenase levels for disease severity and clinical outcomes in patients with colorectal cancer admitted to the intensive care unit.
Wang X; Li C; Li M; Zeng X; Mu J; Li Y
Heliyon; 2024 Jan; 10(1):e23608. PubMed ID: 38173474
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment Inflammatory Markers Predict Outcomes and Prognosis in Colorectal Cancer Patients With Synchronous Liver Metastasis.
Li Q; Chen L; Jin H; Zhao Y; Hao Z; Ma X
Clin Med Insights Oncol; 2022; 16():11795549221084851. PubMed ID: 35355514
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of lactate dehydrogenase levels in colorectal cancer: a meta-analysis.
Li G; Wang Z; Xu J; Wu H; Cai S; He Y
BMC Cancer; 2016 Mar; 16():249. PubMed ID: 27016045
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis.
Zhang M; Wei S; Su L; Lv W; Hong J
Medicine (Baltimore); 2016 Aug; 95(35):e4494. PubMed ID: 27583859
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of Lactate Dehydrogenase Expression in Urologic Cancers: A Systematic Review and Meta-Analysis.
Zhang Y; Xu T; Wang Y; Zhang H; Zhao Y; Yang X; Cao Y; Yang W; Niu H
Oncol Res Treat; 2016; 39(10):592-604. PubMed ID: 27710971
[TBL] [Abstract][Full Text] [Related]
11. Serum lactate dehydrogenase alone is not a helpful prognostic factor in resected colorectal cancer patients.
Caputo D; Caricato M; Vincenzi B; La Vaccara V; Mascianà G; Coppola R
Updates Surg; 2014 Sep; 66(3):211-5. PubMed ID: 25104144
[TBL] [Abstract][Full Text] [Related]
12. Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients.
Scartozzi M; Giampieri R; Maccaroni E; Del Prete M; Faloppi L; Bianconi M; Galizia E; Loretelli C; Belvederesi L; Bittoni A; Cascinu S
Br J Cancer; 2012 Feb; 106(5):799-804. PubMed ID: 22315053
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum lactate dehydrogenase levels in colorectal and gastric cancer: a hospital-based case-control study.
Kostakis ID; Vaiopoulos AG; Philippou A; Papavassiliou AG; Koutsilieris M; Kouraklis G
Biomark Med; 2013 Feb; 7(1):131-7. PubMed ID: 23387494
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
15. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
